HUTCHMED (China) Ltd (HCM) bonds
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 5, 2026Score 5/30
$14.40−0.33 (-2.24%)
Close on Nov 17, 2026Market cap $2.51BP/E 5.5Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$116.91M
$44.81M due within a year
Net debt
$10.36M
After $106.56M of cash
Implied interest rate
2.55%
FY2025 interest ÷ average debt
Interest coverage
-13.7×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in HUTCHMED (China)'s 20-F for the period ended Oct 31, 2025
HUTCHMED (China)'s filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed. The repayment schedule above comes from the same report.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| 10-year fixed asset loan facility | CN¥754.88M |
| Short-term working capital loan facility | CN¥200.00M |
See a number that looks wrong?